Pharmacotherapeutic profile of patients admitted with COVID-19 at a university hospital.

To describe pharmacotherapy in the home and hospital setting and the association with clinical-demographic characteristics of patients hospitalized with COVID-19. Observational, cross-sectional study with retrospective data collection. The variables of interest were medications for COVID-19, chronically used, and used during hospital admission. Non-parametric tests were used to compare and correlate the variables, and the statistical significance adopted was 5%. It was identified that 34.8% of patients used some medication for COVID-19 before hospitalization, and 71.6% (n=255) were undergoing chronic treatments. Azithromycin was the most used medication for COVID-19, and 28.1% of patients had polypharmacy. Days of hospitalization (p=<0.001) and intensive care (p=<0.001) had a strong correlation with the number of medications used. Higher education, impaired renal function, comorbidities, and polypharmacy were associated with the profile of previous users of medications for COVID-19. Intensive care and death were related to a higher number of medications used than other patients. [ABSTRACT FROM AUTHOR]